Yüklüyor......
Esophageal, gastric cancer and immunotherapy: small steps in the right direction?
The treatment of advanced, solid-tumor oncology has been reshaped over the last eight years with the development and FDA approval of several immune checkpoint inhibitors (ICIs) comprised of monoclonal antibodies targeting either PD-1, PD-L1, or CTLA-4 across numerous disease states and indications....
Kaydedildi:
| Yayımlandı: | Transl Gastroenterol Hepatol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7061183/ https://ncbi.nlm.nih.gov/pubmed/32190777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2019.09.05 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|